INTL GENIUS(00033) has received additional resumption guidance from the Stock Exchange and will continue to remain suspended.
INTL GENIUS (00033) announced that on April 10, 2026, the company received a letter from the Stock Exchange, which included additional resumption guidelines for the company.
INTL GENIUS (00033) announced that on April 10, 2026, the company received a letter from the Stock Exchange containing additional resumption guidelines for the company as follows:
Compliance with Listing Rule 3.10(1)
Listing Rule 3.10(1) stipulates that the board of directors of a listed issuer must include at least three independent non-executive directors. The Board of Directors has been made aware of the additional resumption guidelines and is taking proactive steps to rectify this non-compliance.
The company is actively seeking and negotiating the appointment of an additional independent non-executive director to comply with the provisions of Listing Rule 3.10(1). As of the date of this announcement, the company is in discussions with a suitable candidate. The Board of Directors anticipates that the appointment will be finalized and announced within May 2026. Further announcements will be made by the company upon completion of the appointment.
Trading in the company's shares remains suspended.
Related Articles

Sinopec Oilfield Service Corporation (600871.SH) has been approved to issue corporate bonds of up to 5 billion yuan.

HK Stock Market Move | ITC PROPERTIES (00199) closes up nearly 20%, company initiates AI computing power strategic transformation led by Chao Ya Data's founding elders.

Beijing Tongrentang (600085.SH) subsidiary TONGRENTANGCM obtains the Hong Kong Chinese Medicine Registration Certificate.
Sinopec Oilfield Service Corporation (600871.SH) has been approved to issue corporate bonds of up to 5 billion yuan.

HK Stock Market Move | ITC PROPERTIES (00199) closes up nearly 20%, company initiates AI computing power strategic transformation led by Chao Ya Data's founding elders.

Beijing Tongrentang (600085.SH) subsidiary TONGRENTANGCM obtains the Hong Kong Chinese Medicine Registration Certificate.






